clinical trials

hydroxychloroquine trial stops

WHO Stops Hydroxychloroquine Coronavirus Trials Over Safety Concerns

The World Health Organization is temporarily putting a hold on clinical trials for the antimalarial drug, hydroxychloroquine. This decision was after studies showed that the drug potentially caused heart problems and even death. Click the link above to learn more.

Pfizer Announces IBRANCE Clinical Trials Ended Early In Light of Promising News

In light of promising results conducted by an independent data monitoring committee, Pfizer’s newest treatment IBRANCE (Palbociclib) ended clinical trials early this week as phase 3 of the trials ended demonstrating improvement in progression-free survival in women who had undergone treatment for metastatic breast cancer.

Recommended Stories

Real Time Analytics